Atrial natriuretic peptide reverses afferent arteriolar vasoconstriction and potentiates efferent arteriolar vasoconstriction in the isolated perfused rat kidney

R. Loutzenhiser, K. Hayashi, M. Epstein

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

The intrarenal sites of action of atrial natriuretic peptide (ANP) have not been resolved fully. Although ANP relaxes in vitro preparations of smooth muscle and exerts profound effects on renal hemodynamics, the effects of ANP on resistance vessels remain a subject of controversy. In the present study, we utilized an in vitro perfused hydronephrotic rat kidney model to assess directly the actions of ANP on renal microvessels during norepinephrine (NE)-induced renal vascoconstriction. Perfusion pressure was maintained constant, and perfusate flow to the kidney was monitored while the afferent arteriole (AA) and efferent arteriole (EA) were visualized using videomicroscopy. Renal AA and EA diameters were measured by computer-assisted image analysis. NE (0.3 μM) decreased renal perfusate flow from 11.8 ± 1.7 (S.E.) to 5.8 ± 1.2 ml/min (P < .005), decreased AA diameter from 20.2 ± 0.7 to 14.3 ± 0.8 μ (P < .005) and decreased EA diameter from 18.6 ± 1.2 to 15.1 ± 1.2 μ (P < .005). ANP (human ANF- (4-28), anaritide, Wyeth) completely reversed the NE-induced AA vasoconstriction with an IC50 of 9.3 ± 5.6 nM. In contrast, ANP caused a further decrease in EA diameter at concentrations up to 10-8 M, and elicited a slight dilation of the EA at 10-7 M. In normal rat kidneys perfused under identical conditions, NE decreased renal perfusate flow, glomerular filtration rate and filtration fraction. ANP increased glomerular filtration rate and filtration fraction above control levels, with maximal effects at 10-8 M. In concert, these findings indicate that the renal microvessels are important intrarenal sites for the actions of ANP, and that ANP increases glomerular filtration rate and filtration fraction by dilating the AA and potentiating vasoconstriction of the EA.

Original languageEnglish
Pages (from-to)522-528
Number of pages7
JournalJournal of Pharmacology and Experimental Therapeutics
Volume246
Issue number2
Publication statusPublished - 1988

Fingerprint

Arterioles
Atrial Natriuretic Factor
Vasoconstriction
Kidney
Norepinephrine
Glomerular Filtration Rate
Microvessels
Video Microscopy
Computer-Assisted Image Processing
Inhibitory Concentration 50
Smooth Muscle
Dilatation
Perfusion
Hemodynamics
Pressure

ASJC Scopus subject areas

  • Pharmacology

Cite this

@article{18dc3c4d25e04aa8aeae6a5873af28ab,
title = "Atrial natriuretic peptide reverses afferent arteriolar vasoconstriction and potentiates efferent arteriolar vasoconstriction in the isolated perfused rat kidney",
abstract = "The intrarenal sites of action of atrial natriuretic peptide (ANP) have not been resolved fully. Although ANP relaxes in vitro preparations of smooth muscle and exerts profound effects on renal hemodynamics, the effects of ANP on resistance vessels remain a subject of controversy. In the present study, we utilized an in vitro perfused hydronephrotic rat kidney model to assess directly the actions of ANP on renal microvessels during norepinephrine (NE)-induced renal vascoconstriction. Perfusion pressure was maintained constant, and perfusate flow to the kidney was monitored while the afferent arteriole (AA) and efferent arteriole (EA) were visualized using videomicroscopy. Renal AA and EA diameters were measured by computer-assisted image analysis. NE (0.3 μM) decreased renal perfusate flow from 11.8 ± 1.7 (S.E.) to 5.8 ± 1.2 ml/min (P < .005), decreased AA diameter from 20.2 ± 0.7 to 14.3 ± 0.8 μ (P < .005) and decreased EA diameter from 18.6 ± 1.2 to 15.1 ± 1.2 μ (P < .005). ANP (human ANF- (4-28), anaritide, Wyeth) completely reversed the NE-induced AA vasoconstriction with an IC50 of 9.3 ± 5.6 nM. In contrast, ANP caused a further decrease in EA diameter at concentrations up to 10-8 M, and elicited a slight dilation of the EA at 10-7 M. In normal rat kidneys perfused under identical conditions, NE decreased renal perfusate flow, glomerular filtration rate and filtration fraction. ANP increased glomerular filtration rate and filtration fraction above control levels, with maximal effects at 10-8 M. In concert, these findings indicate that the renal microvessels are important intrarenal sites for the actions of ANP, and that ANP increases glomerular filtration rate and filtration fraction by dilating the AA and potentiating vasoconstriction of the EA.",
author = "R. Loutzenhiser and K. Hayashi and M. Epstein",
year = "1988",
language = "English",
volume = "246",
pages = "522--528",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "2",

}

TY - JOUR

T1 - Atrial natriuretic peptide reverses afferent arteriolar vasoconstriction and potentiates efferent arteriolar vasoconstriction in the isolated perfused rat kidney

AU - Loutzenhiser, R.

AU - Hayashi, K.

AU - Epstein, M.

PY - 1988

Y1 - 1988

N2 - The intrarenal sites of action of atrial natriuretic peptide (ANP) have not been resolved fully. Although ANP relaxes in vitro preparations of smooth muscle and exerts profound effects on renal hemodynamics, the effects of ANP on resistance vessels remain a subject of controversy. In the present study, we utilized an in vitro perfused hydronephrotic rat kidney model to assess directly the actions of ANP on renal microvessels during norepinephrine (NE)-induced renal vascoconstriction. Perfusion pressure was maintained constant, and perfusate flow to the kidney was monitored while the afferent arteriole (AA) and efferent arteriole (EA) were visualized using videomicroscopy. Renal AA and EA diameters were measured by computer-assisted image analysis. NE (0.3 μM) decreased renal perfusate flow from 11.8 ± 1.7 (S.E.) to 5.8 ± 1.2 ml/min (P < .005), decreased AA diameter from 20.2 ± 0.7 to 14.3 ± 0.8 μ (P < .005) and decreased EA diameter from 18.6 ± 1.2 to 15.1 ± 1.2 μ (P < .005). ANP (human ANF- (4-28), anaritide, Wyeth) completely reversed the NE-induced AA vasoconstriction with an IC50 of 9.3 ± 5.6 nM. In contrast, ANP caused a further decrease in EA diameter at concentrations up to 10-8 M, and elicited a slight dilation of the EA at 10-7 M. In normal rat kidneys perfused under identical conditions, NE decreased renal perfusate flow, glomerular filtration rate and filtration fraction. ANP increased glomerular filtration rate and filtration fraction above control levels, with maximal effects at 10-8 M. In concert, these findings indicate that the renal microvessels are important intrarenal sites for the actions of ANP, and that ANP increases glomerular filtration rate and filtration fraction by dilating the AA and potentiating vasoconstriction of the EA.

AB - The intrarenal sites of action of atrial natriuretic peptide (ANP) have not been resolved fully. Although ANP relaxes in vitro preparations of smooth muscle and exerts profound effects on renal hemodynamics, the effects of ANP on resistance vessels remain a subject of controversy. In the present study, we utilized an in vitro perfused hydronephrotic rat kidney model to assess directly the actions of ANP on renal microvessels during norepinephrine (NE)-induced renal vascoconstriction. Perfusion pressure was maintained constant, and perfusate flow to the kidney was monitored while the afferent arteriole (AA) and efferent arteriole (EA) were visualized using videomicroscopy. Renal AA and EA diameters were measured by computer-assisted image analysis. NE (0.3 μM) decreased renal perfusate flow from 11.8 ± 1.7 (S.E.) to 5.8 ± 1.2 ml/min (P < .005), decreased AA diameter from 20.2 ± 0.7 to 14.3 ± 0.8 μ (P < .005) and decreased EA diameter from 18.6 ± 1.2 to 15.1 ± 1.2 μ (P < .005). ANP (human ANF- (4-28), anaritide, Wyeth) completely reversed the NE-induced AA vasoconstriction with an IC50 of 9.3 ± 5.6 nM. In contrast, ANP caused a further decrease in EA diameter at concentrations up to 10-8 M, and elicited a slight dilation of the EA at 10-7 M. In normal rat kidneys perfused under identical conditions, NE decreased renal perfusate flow, glomerular filtration rate and filtration fraction. ANP increased glomerular filtration rate and filtration fraction above control levels, with maximal effects at 10-8 M. In concert, these findings indicate that the renal microvessels are important intrarenal sites for the actions of ANP, and that ANP increases glomerular filtration rate and filtration fraction by dilating the AA and potentiating vasoconstriction of the EA.

UR - http://www.scopus.com/inward/record.url?scp=0023753726&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023753726&partnerID=8YFLogxK

M3 - Article

C2 - 2969977

AN - SCOPUS:0023753726

VL - 246

SP - 522

EP - 528

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 2

ER -